Diana Amend

Research activity per year

Targeting NLRP3 inhibits AML progression by inducing PERK/eIF2-mediated apoptosis
Luciano, M., Sieberer, H., Krenn, P. W., Dang, H.-H., Vetter, J., Neuper, T., Amend, D., Blöchl, C., Weichenberger, C. X., Eglseer, A., Unger, M. S., Andosch, A., Steiner, P., Neureiter, D., Bauer, R., Hummer, L., Tesanovic, S., Binder, S., Elmer, D. P. & Strandt, H. & 10 others, Schaller, S., Strunk, D., Pleyer, L., Greil, R., Winkler, S., Hartmann, T. N., Schmidt-Arras, D., Huber, C. G., Aberger, F. & Horejs-Hoeck, J., 2 Sept 2024, In: Cell Communication and Signaling. 22, 1, p. 424 424.
Research output: Contribution to journal › Article › peer-review

Open Access

Collaborations and top research areas from the last five years